Home

Privacy Policy

Scope

This notice provides highlights of the full Eisai Inc. and Pfizer Inc privacy statements and applies to TRUSTe certified Pfizer Web sites.

Visit the TRUSTe Web site to view a complete list of Pfizer Web sites with Validated Privacy Statements.

View the full Eisai Privacy Statement.

View the full Pfizer Privacy Statement.

Personal Information

Generally, you can access and browse our Web sites without disclosing any personally identifiable information.

If you request information, products, or services from our sites, or ask us to resolve complaints or concerns, we may ask you to provide information such as your name, contact information and other identifying information necessary to fulfill a particular request.

We may also collect information a visitor voluntarily provides through responses to questionnaires, surveys, search functions, and health assessment tools.

Eisai and Pfizer sites use cookies and other technologies to identify users as they move through our Web sites. Your Web browser can be set to allow you to control whether you will accept cookies, reject cookies, or to notify you each time a cookie is sent.

Additional Information from Eisai Inc.

Additional Information from Pfizer Inc.

How to Contact Us

With questions about this privacy statement or about the handling of your information please contact:

Eisai Inc.
Privacy Inquiry
100 Tice Blvd.
Woodcliff Lake, NJ 07677

or

The Pfizer Privacy Officer

or

Pfizer Inc
Privacy Officer
235 E. 42 Street
Mail Stop 235/26/6
New York, NY 10017

Pfizer Inc is a TRUSTe licensee. Contact Watchdog dispute resolution if a privacy issue is not properly addressed by us.

Uses

We use personal information you provide to fulfill your request for information, products, or services as per your consent.

We may seek your general consent to provide additional information, products, or services. We give you notice of how your information will be used at the point of collection.

We may personalize our Web sites to provide you with a customized interactive experience, and we may target our marketing and healthcare messaging on those sites based on information we have about you.

We do not sell, rent, or share your personal information with outside third parties. In order to provide services, we may provide information to other companies who work on our behalf. When we do so, we use our best efforts to assure that they agree in writing to abide by Eisai and Pfizer privacy policies.

Additional Information from Eisai Inc.

Additional Information from Pfizer Inc.

Your Rights and Choices

You can unsubscribe from communications you no longer wish to receive. We provide unsubscribe (opt-out) instructions in our communications.

You can also contact the Pfizer Privacy Officer or the postal addresses above if you want to update your personal information or change your marketing preferences.

Additional Information from Eisai Inc.

Additional Information from Pfizer Inc.

Important Information

We do not knowingly collect personally identifiable information from any person under the age of 13 without parental consent.

We have put in place appropriate physical, electronic, and managerial procedures to safeguard and prevent unauthorized access, maintain data security, and correctly use the information we collect online.

Privacy Statement

Eisai and/or Pfizer understands your personal and health information is private. The information you provide will only be used by Eisai and/or Pfizer and parties acting on its behalf. You will only be sent the materials you requested and other helpful information and updates on ARICEPT and/or Alzheimer's as well as related treatments, products, offers, and services.

Eisai Inc. and Pfizer Inc. respect your right to have personal and medical information kept confidential. Due to the personal nature of the materials and Eisai/Pfizer's respect for the privacy of personal medical information, we can only send the materials directly to you.

ARICEPT (donepezil HCl) is a prescription medicine to treat mild Alzheimer’s disease (up to 10 mg/day) and moderate to severe Alzheimer’s disease (up to 23 mg/day).

Before starting on ARICEPT 23 mg/day, patients should be on ARICEPT 10 mg/day for at least 3 months. The starting dose of ARICEPT is 5 mg/day and can be increased to 10 mg/day after 4-6 weeks. Please take ARICEPT as prescribed by the doctor.

Important Safety Information

• ARICEPT^® may not be for everyone. People at risk for stomach ulcers or who take certain other medicines should tell their doctors because serious stomach problems, such as bleeding, may get worse.
• People at risk for certain heart conditions should tell their doctor before starting ARICEPT because they may experience fainting. People with serious lung conditions and difficulty breathing, bladder problems or seizures should tell their doctor before using ARICEPT. ARICEPT 23 mg/day is associated with weight loss. Check with the doctor if this is a concern. Inform the doctor if the patient needs surgery requiring anesthesia while taking ARICEPT.
• Some people may have nausea, diarrhea, difficulty sleeping, vomiting or muscle cramps. Incidence of nausea and vomiting were markedly greater in patients taking ARICEPT 23 mg/day versus patients taking ARICEPT 10 mg/day. Some people may feel tired or may have loss of appetite. If they persist, please talk to the doctor.
  

For full prescribing and patient Information, please visit Prescribing and Patient Information.

The ARICEPT Patient Assistance Program can help qualified indigent and uninsured patients obtain ARICEPT at no cost. Assistance is also available to Medicare Part D-insured patients who are in the coverage gap or donut hole. To learn more and receive an application for assistance, please contact us Monday–Friday from 9 AM to 6 PM ET at: Phone: 1-800-226-2072,

This site is intended for residents of the United States only. The products discussed herein may have different product labeling in different countries.

ARICEPT^® is a registered trademark of Eisai Co., Ltd.
© 2008–2010 Eisai Inc. and Pfizer Inc. All rights reserved. AAR00228

Important Safety Information  |   Prescribing and Patient Info  |   Legal Notices and Disclaimers  |   Privacy Policy